3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Cancer -

Cancer plan progresses but problems remain -MPs

CancerJan 26, 06

A 10-year plan to cut deaths from cancer in England has made significant progress but a clear gap between rich and poor areas of the country remains, a report by an influential committee of MPs said on Thursday.

The government’s NHS Cancer Plan, set up in 2000, aimed to provide a comprehensive strategy for tackling the disease with the creation of 34 networks to improve prevention and diagnosis, and ensure patients received the best treatment.

Currently one in three people develop cancer at some stage in their life.

The Public Accounts Committee said there had been success with falling death rates, better access to drugs and more money getting through to frontline services.

“But there are some areas where progress has not been impressive,” added PAC Chairman Edward Leigh.

The committee said there were clear disparities in the outcome of cancer treatment between affluent and poorer members of society, “with higher mortality rates in deprived areas and survival rates that consistently favour London and the south.”

Some of the established networks were more effective than others, with 30 percent visited by the National Audit Office having no comprehensive plan for providing cancer services in their locality, the PAC report said.

“Many cancer networks, particularly in more deprived areas, are failing to address these problems,” Leigh said. “Their effectiveness needs to be monitored closely and, where necessary, improved.”

The PAC said the Cancer Plan should be reviewed and fresh targets set.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy
  Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy
  New drug for neuroblastoma shows promise in phase I study
  Experimental treatment sends deadly leukemia into remission
  Study could reduce unnecessary cancer screening
  UA researchers discover component of cinnamon prevents colorectal cancer in mice
  Profiling approach to enable right lung cancer treatment match
  Fat grafting technique improves results of breast augmentation
  Germline TP53 mutations in patients with early-onset colorectal cancer
  Clinical trial suggests combination therapy is best for low-grade brain tumors
  UW research shows sensor technology may help improve accuracy of clinical breast exams

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site